Top View
- Protective Effects of Gastric Mucus
- Annexure-1 Patents Granted for Drugs (Products and Processes)
- A Comparative Evaluation of Lafutidine and Rabeprazole in the Treatment of Gastritis and Peptic Ulcer: a Double-Blind, Randomized Study in Indian Patients
- WO 2015/155297 Al 15 October 2015 (15.10.2015) P O P C T
- Histamine-2 Receptor Antagonists (H2RA) May Negatively Impact ADL Assessment in Patients on a Convalescent Rehabilitation Ward
- Known Bioactive Library: Selleck Bioactive 10Mm, 3.33Mm, 1.11Mm
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Product List
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- The Pharmaceuticals and Medical Devices Agency
- Pharmaabkommen A1 E
- Lafutidine 10 Mg Versus Rabeprazole 20 Mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: a Randomized, Multicentric Trial
- PRODUCED by Pharmaqx Report For
- Customs Tariff - Schedule Xxi - 1
- Wo 2007/044693 A2
- (CD-P-PH/PHO) Report Classification/Justifica
- ERS Guidelines on the Diagnosis and Treatment of Chronic Cough in Adults and Children
- 2020 Ranitidine and Other Histamine-H2
- Roles of Histamine and Its Receptors in Allergic and Inflammatory Bowel Diseases
- Harmonized Tariff Schedule of the United States (2006) (Rev
- Pharmaceutical Composition Pharmazeutische Zusammensetzung Composition Pharmaceutique
- Pharmaceutical Combinations of Rivaroxaban and H2-Receptor Antagonists
- Lafutidine Changes Levels of Somatostatin, Calcitonin Gene-Related Peptide, and Secretin in Human Plasma
- Drug Repurposing Compound Library Plus (96-Well)
- WO 2012/173581 Al 20 December 2012 (20.12.2012) P O P C T
- Research Journal of Pharmaceutical, Biological and Chemical Sciences
- Association of Gastric Acid Suppression with Recurrent Clostridium Difficile Infection: a Systematic Review and Meta-Analysis
- (12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
- Prediction of Change in Prescription Ingredient Costs and Co-Payment Rates Under a Reference Pricing System in South Korea Ji Haeng Heo, MS1, Karen L
- Lafutidine-Induced Increase in Intracellular Ca Concentrations In
- (12) United States Patent (10) Patent No.: US 8,802,596 B2 Rogers Et Al
- WO 2016/192680 Al 8 December 2016 (08.12.2016) P O P C T
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Principali Interazioni Dei Farmaci Onco-Ematologici Con Farmaci, Fitoterapici Ed Alimenti
- Afferent Signalling from the Acid-Challenged Rat Stomach Is
- Effect of Ranitidine Intake on the Risk of Gastric Cancer Development
- Drug Repurposing Compound Library (96-Well)
- Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Lafutidine 10Mg) in Patients with Acid Peptic Disorders in India
- Floating Microsponges As Gastro Retentive Drug Delivery System Containing Lafutidine to Treat Gastric Ulcer
- ICD-9) Used in This Study